Redmile Group »

Rapt Therapeutics shares owned by Redmile Group

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Redmile Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.1M 367k 24.85
2023-09-30 $7.1M 428k 16.62
2023-06-30 $8.1M 432k 18.70
2023-03-31 $13M 688k 18.35
2022-12-31 $16M 785k 19.80
2022-09-30 $19M 785k 24.06
2022-06-30 $15M 818k 18.25
2022-03-31 $17M 749k 21.99